Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “WHIM”

79 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 79 results

Early research (Phase 1)Ended earlyNCT03277209
What this trial is testing

To Assess the Safety of Continuous IV Administration of Plerixafor and Assess Impact on the Immune Microenvironment in Patients With Pancreatic, Ovarian and Colorectal Adenocarcinomas

Who this might be right for
Pancreas Cancer
Weill Medical College of Cornell University 2
Early research (Phase 1)Study completedNCT01841476
What this trial is testing

Safety and Efficacy of POL6326 for Mobilization of Hematopoietic Stem Cells in Healthy Volunteers

Who this might be right for
Healthy
Polyphor Ltd. 27
Not applicableUnknownNCT00173849
What this trial is testing

The Role of SDF-1/CXCR4 in Metastasis of Oral Squamous Cell Carcinoma

Who this might be right for
Oral Cancer
National Taiwan University Hospital 100
Not applicableUnknownNCT05815069
What this trial is testing

[18F]AlF-NOTA-pentixather PET/CT in Patients With Suspected Primary Hyperaldosteronism

Who this might be right for
Aldosterone-Producing Adenoma
Sichuan Provincial People's Hospital 20
Testing effectiveness (Phase 2)Study completedNCT02907099
What this trial is testing

Pembrolizumab and CXCR4 Antagonist BL-8040 in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic AdenocarcinomaRecurrent Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v6 and v7
M.D. Anderson Cancer Center 20
Not applicableStudy completedNCT03891485
What this trial is testing

Nivolumab in mRCC Patients: Treg Function, T-cell Access and NK Interactions to Predict and Improve Efficacy

Who this might be right for
RCCMetastatic Renal Cell Carcinoma
National Cancer Institute, Naples 200
Not applicableStudy completedNCT06247566
What this trial is testing

68Ga-Pentixafor PET/CT for Guiding Surgical Treatment of Primary Aldosteronism With Bilateral Adrenal Lesions

Who this might be right for
Primary Aldosteronism With Bilateral Adrenal Lesions
Central South University 83
Early research (Phase 1)Study completedNCT06547112
What this trial is testing

A Pharmacodynamic Study of the Apheresis Product of Multiple Myeloma Patients Undergoing Quad-induction Followed by Motixafortide + G-CSF Mobilization

Who this might be right for
Multiple Myeloma
Washington University School of Medicine 20
Testing effectiveness (Phase 2)WithdrawnNCT02115672
What this trial is testing

Imatinib and BL-8040 (Novel Anti CXCR4 Antagonist) for Improving Molecular Response in Chronic Myelogenous Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Sheba Medical Center
Not applicableLooking for participantsNCT06999954
What this trial is testing

Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform

Who this might be right for
Shwachman-Diamond SyndromeSDSIBMF+24 more
Shwachman-Diamond Syndrome Alliance Inc 8,000
Large-scale testing (Phase 3)WithdrawnNCT00243568
What this trial is testing

Vicriviroc, a CCR5 Inhibitor, Added to an Optimized Antiretroviral Therapy for Previously Treated HIV (VICTOR-E2) (Study P04285

Who this might be right for
HIV InfectionsAcquired Immunodeficiency Syndrome
Merck Sharp & Dohme LLC
Very early researchStudy completedNCT03020524
What this trial is testing

Autologous CD4 T-Cells in HIV (C34-CXCR4)

Who this might be right for
Hiv
University of Pennsylvania 9
Very early researchActive Not RecruitingNCT03335670
What this trial is testing

Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Yusuf Menda 30
Testing effectiveness (Phase 2)Ended earlyNCT02765165
What this trial is testing

Phase 1/2 Study of USL311 +/- Lomustine in Advanced Solid Tumors or Relapsed/Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Solid Tumors (Phase 1)Relapsed/Recurrent GBM (Phase 2)
Proximagen, LLC 26
Not applicableUnknownNCT04799730
What this trial is testing

Expression of CXCR4 in Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Sohag University 100
Early research (Phase 1)Study completedNCT00322127
What this trial is testing

An Evaluation of Safety and Efficacy of Escalating Doses of AMD3100 to Mobilize CD34+ Cells in Healthy Volunteers

Who this might be right for
Healthy Volunteers
National Heart, Lung, and Blood Institute (NHLBI) 44
Testing effectiveness (Phase 2)Study completedNCT00082329
What this trial is testing

G-CSF and AMD3100 to Mobilize Stem Cells in Healthy Volunteers

Who this might be right for
Healthy
National Heart, Lung, and Blood Institute (NHLBI) 9
Testing effectiveness (Phase 2)Study completedNCT01010880
What this trial is testing

Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Biokine Therapeutics Ltd 16
Large-scale testing (Phase 3)Looking for participantsNCT06056297
What this trial is testing

Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

Who this might be right for
Neutropenia
X4 Pharmaceuticals 176
Early research (Phase 1)Ended earlyNCT02737072
What this trial is testing

LY2510924 and Durvalumab in Participants With Solid Tumors

Who this might be right for
Solid Tumor
Eli Lilly and Company 9
Load More Results